A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study

OBJECTIVE: To compare the efficacy of agomelatine with escitalopram in the treatment of major depressive disorder (MDD), improve sleep in MDD patients and study the adverse effects of agomelatine. MATERIALS AND METHODS: Randomized, parallel-group, open-label study. The primary efficacy outcome was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Urade, Chetan S., Mahakalkar, Sunil M., Tiple, Prashant G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714386/
https://www.ncbi.nlm.nih.gov/pubmed/26813706
http://dx.doi.org/10.4103/0976-500X.171883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714386/
https://www.ncbi.nlm.nih.gov/pubmed/26813706
http://dx.doi.org/10.4103/0976-500X.171883

Ejemplares similares